Media Kit
Wesper press resources.
Company facts, brand assets, recent coverage and media contacts.

Wesper at a Glance
The facts, ready to cite.
Company
- Founded in 2017, headquartered in New York
- Co-founder and CEO: Amir Reuveny, Ph.D.
- About $13.9M raised, including a $9.6M Series A (2022)
- Investors include Valor Equity Partners, Breyer Capital and Spark Capital
Products
- Wesper Lab: FDA-cleared home sleep apnea test with direct respiratory data (K203343)
- Wesper Lite: FDA-cleared, PPG-based home sleep apnea test, powered by Cassie (K252628)
- One provider portal, patient record and interpretation pipeline
Proof Points
- 95%+ AHI correlation to in-lab PSG
- 99%+ patient success rate (Wesper, Q3 2026)
- SOC 2 Type 2 and HIPAA compliant
- TIME Best Inventions of 2026, Special Mention
Wesper is not a wearable. It's a medical-grade diagnostic tool trusted by leading physicians, health systems, and sleep specialists.
Recent Press
Releases and coverage.
Brand Assets
Logos, images and video.
Please follow the logo guidelines included in the branding package.
Common Media Questions
Wesper, in brief.
What is Wesper?
Wesper develops FDA-cleared home sleep testing medical devices. Our multi-tier ecosystem brings together two levels of testing, Wesper Lab and Wesper Lite, with a clinical portal and a managed service for dropship, patient support and optional interpretation.
What problem does Wesper solve?
An estimated 84 million Americans have obstructive sleep apnea, and around 80% are undiagnosed. With roughly one board-certified sleep physician for every 45,000 Americans (AASM; U.S. Census Bureau), the bottleneck is access. Wesper expands home testing so more patients get diagnosed and followed over time.
How is Wesper different?
Wesper is a multi-tier ecosystem. Physicians match the right test to each patient: Wesper Lab for direct respiratory data in complex cases, Wesper Lite for screening and remote monitoring, on one workflow and one patient record.
How does Wesper work?
Providers order a test in the Wesper portal or their EMR. Wesper dropships the kit to the patient, guides them through multi-night testing with 24/7 support, and returns scored studies to the clinic, with optional interpretation by board-certified sleep physicians.
Who can I speak to?
Media requests are handled by our team through the contact form. Our spokesperson is co-founder and CEO Amir Reuveny, Ph.D.
Media Requests
Talk to our team.
Interview requests, press inquiries and speaking opportunities.
Send a media request






